Movatterモバイル変換


[0]ホーム

URL:


GB0501475D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0501475D0
GB0501475D0GB0501475AGB0501475AGB0501475D0GB 0501475 D0GB0501475 D0GB 0501475D0GB 0501475 AGB0501475 AGB 0501475AGB 0501475 AGB0501475 AGB 0501475AGB 0501475 D0GB0501475 D0GB 0501475D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0501475A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astex Technology Ltd
Original Assignee
Astex Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astex Technology LtdfiledCriticalAstex Technology Ltd
Priority to GB0501475ApriorityCriticalpatent/GB0501475D0/en
Publication of GB0501475D0publicationCriticalpatent/GB0501475D0/en
Priority to GT200600012Aprioritypatent/GT200600012A/en
Priority to TW095101703Aprioritypatent/TWI455932B/en
Priority to MYPI20060217prioritypatent/MY148886A/en
Priority to ARP060100203Aprioritypatent/AR054425A1/en
Priority to BRPI0606594-5Aprioritypatent/BRPI0606594A2/en
Priority to RU2007131100/04Aprioritypatent/RU2410385C2/en
Priority to PE2009001082Aprioritypatent/PE20091785A1/en
Priority to AU2006207323Aprioritypatent/AU2006207323B2/en
Priority to MX2007008783Aprioritypatent/MX2007008783A/en
Priority to PCT/GB2006/000207prioritypatent/WO2006077426A2/en
Priority to CA2593560Aprioritypatent/CA2593560C/en
Priority to NZ556471Aprioritypatent/NZ556471A/en
Priority to US11/814,458prioritypatent/US8013163B2/en
Priority to CN200680009244.XAprioritypatent/CN101146791B/en
Priority to EP06700762.5Aprioritypatent/EP1846393B1/en
Priority to PE2006000078Aprioritypatent/PE20061018A1/en
Priority to JP2007551745Aprioritypatent/JP5184892B2/en
Priority to SA6260465Aprioritypatent/SA06260465B1/en
Priority to IL184504Aprioritypatent/IL184504A/en
Priority to TNP2007000277Aprioritypatent/TNSN07277A1/en
Priority to NO20073957Aprioritypatent/NO340738B1/en
Priority to MA30146Aprioritypatent/MA29256B1/en
Priority to KR1020077018925Aprioritypatent/KR101344691B1/en
Priority to US13/188,887prioritypatent/US8293767B2/en
Ceasedlegal-statusCriticalCurrent

Links

GB0501475A2005-01-212005-01-22Pharmaceutical compoundsCeasedGB0501475D0 (en)

Priority Applications (25)

Application NumberPriority DateFiling DateTitle
GB0501475AGB0501475D0 (en)2005-01-222005-01-22Pharmaceutical compounds
GT200600012AGT200600012A (en)2005-01-212006-01-11 PHARMACEUTICAL COMPOUNDS
TW095101703ATWI455932B (en)2005-01-212006-01-17Acid addition salts of, processes for preparing, and uses of 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide
MYPI20060217MY148886A (en)2005-01-212006-01-18Pharmaceutical compounds
ARP060100203AAR054425A1 (en)2005-01-212006-01-19 PIPERIDIN ADDITION SALTS 4-IL-ACID AMID 4- (2,6-DICLORO-BENZOILAMINO) 1H-PIRAZOL-3-CARBOXILICO.
JP2007551745AJP5184892B2 (en)2005-01-212006-01-20 Acid addition salts of 4- (2,6-dichloro-benzoylamino) -1H-pyrazole-3-carboxylic acid piperidin-4-ylamide as kinase inhibitors
NZ556471ANZ556471A (en)2005-01-212006-01-204-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
PE2006000078APE20061018A1 (en)2005-01-212006-01-20 PIPERIDIN-4-ILAMINE ACID ADDITION SALTS OF 4- (2,6-DICHLORO-BENZOYL-AMINO) -1H-PIRAZOL-3-CARBOXYL ACID AS KINASE INHIBITORS
PE2009001082APE20091785A1 (en)2005-01-212006-01-20 PIPERIDIN-4-ILAMIDE ACID ADDITION SALTS FROM 4- (2,6-DICHLORO-BENZOIL-AMINO) -1H-PIRAZOL-3-CARBOXYL ACID
AU2006207323AAU2006207323B2 (en)2005-01-212006-01-204- (2, 6-dichlorobenzoylamino) -lH-pyrazole-3 -carboxylic acid piperidin- 4 -ylamid acid addition salts as kinase inhibitors
MX2007008783AMX2007008783A (en)2005-01-212006-01-204- (2, 6-DICHLOROBENZOYLAMINO) -lH-PYRAZOLE-3 -CARBOXYLIC ACID PIPERIDIN- 4 -YLAMID ACID ADDITION SALTS AS KINASE INHIBITORS.
PCT/GB2006/000207WO2006077426A2 (en)2005-01-212006-01-204- (2, 6-DICHLOROBENZOYLAMINO) -lH-PYRAZOLE-3 -CARBOXYLIC ACID PIPERIDIN- 4 -YLAMID ACID ADDITION SALTS AS KINASE INHIBITORS
CA2593560ACA2593560C (en)2005-01-212006-01-20Pharmaceutical compounds
BRPI0606594-5ABRPI0606594A2 (en)2005-01-212006-01-20 acid addition salt, preparation method, aqueous solution as well as use thereof, process for preparing 4- (2,6-dichloro-benzoylamino) -1h-pyrazol-3-carboxylic acid piperidin-4-ylamide and use thereof, pharmaceutical composition and chemical intermediate
US11/814,458US8013163B2 (en)2005-01-212006-01-204-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
CN200680009244.XACN101146791B (en)2005-01-212006-01-204-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamid acid addition salts as kinase inhibitors
EP06700762.5AEP1846393B1 (en)2005-01-212006-01-204-(2,6-dichlorobenzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
RU2007131100/04ARU2410385C2 (en)2005-01-212006-01-20Compounds for application in pharmaceutics
SA6260465ASA06260465B1 (en)2005-01-212006-01-214-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide Acid Addition Salts
IL184504AIL184504A (en)2005-01-212007-07-09Acid addition salts of 4-(2,6-dichlorobenzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide, methods of preparing them, pharmaceutical compositions and aqueous solutions comprising the same
TNP2007000277ATNSN07277A1 (en)2005-01-212007-07-20Pharmaceutical compounds
NO20073957ANO340738B1 (en)2005-01-212007-07-27 Pharmaceutical compounds
MA30146AMA29256B1 (en)2005-01-212007-08-16 PHARMACEUTICAL COMPOUNDS
KR1020077018925AKR101344691B1 (en)2005-01-212007-08-17 4- (2,6-dichloro-benzoylamino) -1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salt as a kinase inhibitor
US13/188,887US8293767B2 (en)2005-01-212011-07-224-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB0501475AGB0501475D0 (en)2005-01-222005-01-22Pharmaceutical compounds

Publications (1)

Publication NumberPublication Date
GB0501475D0true GB0501475D0 (en)2005-03-02

Family

ID=34259610

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB0501475ACeasedGB0501475D0 (en)2005-01-212005-01-22Pharmaceutical compounds

Country Status (4)

CountryLink
GB (1)GB0501475D0 (en)
GT (1)GT200600012A (en)
MY (1)MY148886A (en)
TW (1)TWI455932B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US9872445B2 (en)2010-09-302018-01-23The Toro CompanyTurf management
CN116283779B (en)*2023-03-292024-10-18河南大学 Carboxylic acid Schiff base, preparation method and application thereof as corrosion inhibitor for metals and their alloys

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB0102687D0 (en)*2001-02-022001-03-21Pharmacia & Upjohn SpaOxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them

Also Published As

Publication numberPublication date
MY148886A (en)2013-06-14
TWI455932B (en)2014-10-11
GT200600012A (en)2006-08-09
TW200639167A (en)2006-11-16

Similar Documents

PublicationPublication DateTitle
GB0501999D0 (en)Pharmaceutical compounds
GB0520657D0 (en)Pharmaceutical compounds
EP1909576A4 (en)Novel pharmaceutical compounds
IL182615A0 (en)Pharmaceutical compounds
AP2008004533A0 (en)Pharmaceutical combination
GB0520656D0 (en)Pharmaceutical compounds
IL188438A0 (en)New pharmaceutical compounds
IL181229A0 (en)Noncardiotoxic pharmaceutical compounds
ZA200804666B (en)Pharmaceutical combination
GB0512643D0 (en)Pharmaceutical compounds
GB0424742D0 (en)Pharmaceutical compounds
ZA200705612B (en)Pharmaceutical compounds
GB0428554D0 (en)Pharmaceutical compounds
GB0512246D0 (en)Novel pharmaceutical
GB0501475D0 (en)Pharmaceutical compounds
GB0512642D0 (en)Pharmaceutical compounds
GB0526607D0 (en)Pharmaceutical compounds
GB0516790D0 (en)Pharmaceutical compounds
GB0516167D0 (en)Pharmaceutical compounds
GB0512681D0 (en)Pharmaceutical compounds
GB0512654D0 (en)Pharmaceutical compounds
GB0501310D0 (en)Pharmaceutical compounds
GB0511884D0 (en)Pharmaceutical compounds
GB0510252D0 (en)Pharmaceutical compounds
GB0501480D0 (en)Pharmaceutical compounds

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)

[8]ページ先頭

©2009-2025 Movatter.jp